tirzepatide vs semaglutide side effects comparison study as Compared with for the Treatment of Obesity When it comes to semaglutide

Acute Gallbladder Disease In a pool of Study 1 and 2, cholelithiasis was reported in 1.1% of ZEPBOUND-treated patients and 1% of placebo-treated patients, cholecystitis was reported in 0.7% of ZEPBOUND-treated patients and 0.2% of placebo-treated patients, and cholecystectomy was reported in 0.2% of ZEPBOUND-treated patients and no placebo-treated patients

This additional responsibility comes with additional risk of error, which is why resources like SeekPeptides are valuable

What does that say about me

Sergey Terushkin, MD, FACS Florida Surgery & Weight Loss Center Hollywood, FL GLP-1 medications like semaglutide and tirzepatide are widely used for weight loss across Florida

With weight regain comes the return of obesity-related fatigue, inflammation, insulin resistance, and potentially sleep apnea